Xenon Ophthalmics Inc
Biotechnology company · Belleville, New Jersey, United States
Xenon Ophthalmics Inc is a biotechnology company headquartered in Belleville, New Jersey, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $2.4 million sold in a notice filed in 2023.
Xenon Ophthalmics at a glance
What does Xenon Ophthalmics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2.4 million sold (2023).
Frequently asked questions about Xenon Ophthalmics
Where is Xenon Ophthalmics headquartered?
Xenon Ophthalmics Inc is headquartered in Belleville, New Jersey, United States.
What does Xenon Ophthalmics do?
Xenon Ophthalmics Inc is a biotechnology company.
When was Xenon Ophthalmics founded?
The earliest incorporation on record for Xenon Ophthalmics Inc is in 2019, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences